Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Are These the Worst 5 Shares on the FTSE 100?

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

LONDON -- Singling out good stocks is quite an art, but what about bad stocks? For the last few months, I have been working through the FTSE 100 (UKX), looking for great opportunities. Along the way, I have found plenty to avoid. Are these the worst five stocks on the FTSE 100? And if so, how come I own three of them?

Royal Bank of Scotland
Like most people in the U.K., I loathe Royal Bank of Scotland  (LSE: RBS  ) . Its arrogance cost taxpayers hundreds of millions. It's a bad bank, propped up by the state, which owns 85% of it. One day, that stake will have to be offloaded, which could wreak further damage on its share price. Like all banks, it still attracts scandals like jam attracts wasps. RBS has also been accused of abandoning U.K. PLC by failing to lend during the downturn. Worst of all, like most big banks, its vast, sprawling balance sheet is impossible for ordinary mortals to understand. RBS is so bad it is almost good, which is why I bought its shares a couple of years ago at 21 pence. They now trade at 35 pence, a rise of 67%. Do I hate RBS, or do I hate myself even more for speculating on it?

Here's another stock I hate myself for holding: pharmaceutical giant GlaxoSmithKline  (LSE: GSK  ) . Unlike RBS, this one has hardly made me any money since I bought it five years ago. What I find astonishing is that it still has such a healthy reputation with investors. It is more likely to figure in the best five FTSE 100 stocks, rather than the worst. That annoys me as well. So does the fact that it recently extended the amount of time it takes to pay suppliers from 60 days to 90 days, a sneaky move that has drawn anger from small businesses. Most annoying of all, its share price is down nearly 10% since last summer. So much for defensive pharmaceutical stocks. Crikey, even AstraZeneca has done better lately. Glaxo has also seen drugs sales fall in austerity-stricken Europe, and I worry that more bad news could follow. On the plus side, there is that 5.1% yield. There may be far worse stocks on the FTSE 100, but few are quite as frustrating.

Wholesale broking business ICAP  (LSE: IAP  )  has found it tough since the financial crisis, thanks to a slump in derivatives trading. After a series of profit downgrades, it is trading at roughly half its peak value five years ago, and the slide continues. It has fallen more than 40% in the last 12 months alone. Chief executive Michael Spencer has called this one of the toughest periods of his career, and you can see why. It is always darkest before the dawn, however, and some of you might consider this a contrarian buy. Broker Prime Markets recently called ICAP "a recovery to buy into." If you agree, this stock's 6.8% yield will reward you for your patience, but you may have to be very patient indeed.

BG Group
What can you say about a stock that has just admitted it won't grow this year, and probably won't do much better next year as well? The stock market knew exactly how to respond, which is why BG Group's (LSE: BG  )  share price plunged 20% last year. I treated this as a buying opportunity, but I'm beginning to suffer buyer's regret, as the share price has little reason to go anywhere right now. There has been a spark of good news this year, with production starting on time and on budget at the group's Sapinhoa offshore field in Brazil. There has even been some takeover speculation, with rumours of a bid from Royal Dutch Shell and Petrobras. Again, buyers will have to be patient, only this time they will receive scant reward from the dividend, which yields just 1.4%. BG Group owes its investors better than that.

Admiral Group
When I last looked at Admiral Group  (LSE: ADM  ) , the thing I like most was its subsidiary brand, one of the best-established price comparison sites in the U.K. But the group is sailing through choppy waters right now. Its most recent trading update saw a 2% drop in quarterly turnover to 570 million pounds, year over year, as premium rates fell in the cyclical car insurance market. This is a highly competitive market, and Admiral may struggle to replicate its stellar growth of the last 20 years. It is a financially solid business, so there is little reason for investors to worry, but little reason to get excited either. Especially on a dividend yield of 3.2%, that can be bettered elsewhere.

Great eight
So, that's five stocks I won't be buying. If you want to know what you should be buying, then read our special in-depth report "Eight Top Blue Chips Held by Britain's Super Investor."

The report by Motley Fool analysts is completely free and shows where Invesco-Perpetual's dividend maestro Neil Woodford believes the best high-yield stocks are to be found today. Availability of this report is strictly limited, so please download it now.

Read/Post Comments (1) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On January 21, 2013, at 7:18 AM, jseth123 wrote:

    I'm not sure about the 5 worst stocks on the FTSE100, but I am sure this is one of the worst articles I have read on this website!

    "RBS is so bad it is almost good, which is why I bought its shares a couple of years ago at 21 pence. They now trade at 35 pence, a rise of 67%." - you clearly have emotional attachment to your purchases. Everything has its price, it looks like you found RBS's.

    "Most annoying of all, its share price is down nearly 10% since last summer" - talk about long term ownership of businesses with a moat.

    "dividend, which yields just 1.4%. BG Group owes its investors better than that." - alternatively, BG has large capex requirements to get these projects on stream.

    How long have you been investing?!

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2204596, ~/Articles/ArticleHandler.aspx, 9/30/2016 1:08:54 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,325.77 182.32 1.00%
S&P 500 2,169.99 18.86 0.88%
NASD 5,316.04 46.88 0.89%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/30/2016 12:01 PM
ADM $2049.38 Down -34.62 -1.66%
Admiral Group CAPS Rating: No stars
BG $0.00 Down +0.00 +0.00%
BG Group CAPS Rating: No stars
GSK $1640.77 Down -6.73 -0.41%
GlaxoSmithKline CAPS Rating: No stars
IAP $465.78 Down -0.42 -0.09%
ICAP CAPS Rating: No stars
RBS $169.69 Down -7.41 -4.18%
Royal Bank of Scot… CAPS Rating: No stars